Psychiatric disorders – including ADHD, Bipolar Disorder, Depression (MDD and TRD), Anxiety Disorders, and Schizophrenia – demand sophisticated understanding of disease progression, treatment complexity, symptom management, and patient outcomes . As the therapeutic landscape expands with novel psychotropic agents, psychotherapy innovations, and emerging targeted interventions, obtaining high-quality real-world evidence is critical to support clinical strategies, inform healthcare decisions, and demonstrate clinical and quality-of-life value to key stakeholders.
Adelphi Real World’s Disease Specific Programmes (DSPs) are purpose-built to address these challenges.
Our Psychiatric Disorders DSPs provide comprehensive, actionable real-world data and insights tailored to the distinctive features of mental health conditions and psychiatric treatment. By engaging directly with psychiatrists, primary care physicians, Physician assistants in Psychiatry/ Psychiatric Nurse Practitioners, patients, and caregivers, our DSPs deliver granular perspectives on:
Treatment Sequencing & Management Patterns
Understand real-world therapy selection, combination strategies, and sequential treatment approaches across psychiatric condition types, disease stages, patient demographics, and healthcare systems – capturing adoption of emerging therapies and treatment decision pathways in routine psychiatric practice.
Physician Decision-Making
Explore the clinical reasoning behind treatment choices, factors influencing therapy selection, psychopharmacology sequencing, psychotherapy integration strategies, comorbidity management approaches, and strategies for symptom monitoring and functional assessment.
Patient & Caregiver Experiences & Outcomes
Document real-world efficacy, tolerability profiles, symptom control, functional restoration, medication side effects, treatment adherence, work and lifestyle impact, quality of life, caregiver burden, support needs, and lived experiences in everyday clinical settings – revealing gaps between trial data and real-world patient and family experience across psychiatric disorder populations.
Emerging Unmet Needs
Uncover persistent treatment challenges, gaps in psychiatric management, emerging therapeutic opportunities, treatment-resistant disorder prevention strategies, medication side effect burden, treatment adherence barriers, caregiver support gaps, and opportunities for therapeutic innovation to better serve patients with psychiatric disorders.
Psychiatric Disorder Disease Specific Programmes (DSP) Portfolio
Why Partner With Adelphi Real World for Psychiatric Disorder Research?
Extensive Global Coverage
Our DSP network spans multiple countries, providing robust comparative insights into psychiatric practice, treatment adoption, diagnostic approaches, and healthcare delivery across diverse healthcare systems.
Deep Clinical Expertise
With specialised knowledge of psychiatric disorders, we ensure our data collection, analysis, and interpretation reflect the true complexity of mental health disease management and the needs of treating clinicians, patients and supporting caregivers.
Evidence That Drives Impact
From clinical development to reimbursement and healthcare provider engagement, our psychiatric disorder DSPs provide the credible, compelling evidence needed to influence decisions across the healthcare ecosystem.
Psychiatric Disorder DSP Coverage
Who We Work With
We partner strategically with psychiatry practices, mental health centres, hospital networks, primary care facilities, to generate evidence that transforms psychiatric disorder care globally.
Let’s Get Started
-
Schedule a Consultation: Meet with our psychiatric disorder specialists to discuss how our DSPs can support your research, development, and market access objectives across ADHD, Bipolar Disorder, Depression (MDD and TRD), Anxiety Disorders, and Schizophrenia.
-
Get More Details: Want to explore our methodology, disease focus areas, global reach, patient and caregiver insights? We’re here to answer your questions and provide customised information.
Adelphi Real World brings together real-world expertise, psychiatric disorder insight, and global reach to help you succeed in mental health research. Let’s collaborate to advance evidence and improve outcomes for patients with psychiatric disorders.
Contact us today using the form below.
Conferences Attending
Observational Research